Johnson Rice analyst Charles Meade downgrades EOG Resources (NYSE:EOG) from Buy to Hold and lowers the price target from $177 to $163.
Here’s How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 6.64% on an annualized basis producing an average annual return of 17.25%. Currently, Vertex Pharmaceuticals has a market capitalization of $72.31 billion.
